A modified DCF regimen as primary treatment for patients with metastatic gastric cancer

Koca, D.; Dogan, E.; Yardim, H.; Duzen, O.; Karaca, S.

A modified DCF regimen as primary treatment for patients with metastatic gastric cancer

Koca D., Dogan E., Yardim H., Duzen O., Karaca S.

JOURNAL OF BUON, vol.18, no.2, pp.377-384, 2013 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 18 Issue: 2
Publication Date: 2013
Journal Name: JOURNAL OF BUON
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.377-384
Van Yüzüncü Yıl University Affiliated: Yes

Abstract

Purpose: To retrospectively assess the efficacy and toxity of a modified docetaxel, cisplatin, fluorouracil (mDCF) regimen as primary treatment in patients with metastatic gastric cancer (MGC).